Table II.
Group | Animal number | Bone | Soft-tissue | Cement spacer | Total |
---|---|---|---|---|---|
Antibiotic-free spacer | 1 | 1.875 × 105 | 3.54 × 105 | 1.45 × 105 | 6.86 × 105 |
2 | 3.75 × 105 | 2.28 × 105 | 3.22 × 105 | 9.25 × 105 | |
3 | 3.50 × 105 | 1.84 × 105 | 6.43 × 105 | 1.17 × 106 | |
4 | 1.52 × 105 | 2.08 × 105 | 4.50 × 105 | 8.10 × 105 | |
5 | 1.80 × 105 | 6.60 × 105 | 3.54 × 105 | 1.19 × 106 | |
6 | 5.20 × 105 | 1.44 × 105 | 4.38 × 105 | 1.10 × 106 | |
7 | 9.20 × 104 | 4.96 × 105 | 2.88 × 105 | 8.76 × 105 | |
Van-spacer | 1 | 6.55 × 104 | 2.86 × 104 | 520 | 9.46 × 104 |
2 | 2.84 × 104 | 4.52 × 104 | 738 | 7.43 × 104 | |
3 | 1.25 × 105 | 4.36 × 105 | 86 | 5.61 × 105 | |
4 | 4.34 × 104 | 3.70 × 104 | 475 | 8.08 × 104 | |
5 | 1.66 × 104 | 2.94 × 105 | 120 | 3.11 × 105 | |
6 | 5.35 × 104 | 8.60 × 104 | 323 | 1.39 × 105 | |
7 | 1.84 × 104 | 1.27 × 105 | 60 | 1.45 × 105 | |
IP & Van-spacer | 1 | 24 | 36 | 50 | 110 |
2 | 37 | 240 | 26 | 303 | |
3 | 25 | 127 | 38 | 190 | |
4 | 38 | 820 | 225 | 1083 | |
5 | 50 | 96 | 44 | 190 | |
6 | 0 | 0 | 0 | 0 | |
7 | 132 | 54 | 128 | 314 | |
IA & Van-spacer | 1 | 0 | 0 | 0 | 0 |
2 | 0 | 0 | 0 | 0 | |
3 | 0 | 0 | 0 | 0 | |
4 | 0 | 0 | 0 | 0 | |
5 | 0 | 0 | 0 | 0 | |
6 | 0 | 0 | 0 | 0 | |
7 | 0 | 0 | 0 | 0 |
The four treatment groups: Control (antibiotic-free cement spacer); Van-Cement spacer (4 g vancomycin per 40 g cement powder); IP & Van-Cement spacer (4 g vancomycin per 40 g cement powder, and IP injection of vancomycin, 88 mg/kg, 1 ml, every 12 hours); IA & Van-Cement spacer (4 g vancomycin per 40 g cement powder, and IA injection of vancomycin, 44 mg/kg, 150 µl, once per day); n = 7. The limit of detection of bacteria in the culture results was 0 colony-forming units, and each sample was tested in triplicate repeatedly and averaged.
IA, intra-articular; IP, intraperitoneal; Van, vancomycin.